Seres Therapeutics's total assets for Q4 2024 were $139.81M, a decrease of -21.78% from the previous quarter. DE:1S9 total liabilities were $126.03M for the fiscal quarter, a -18.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.